Haiwen Huang

A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

Yuqin Song, Jianqiu Wu, Xinchuan Chen et al. · Clinical Cancer Research · 2019 · 157 citations

Medicine, Oncology, Pharmacology +17

Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study

Wei Xu, Shenmiao Yang, Keshu Zhou et al. · Journal of Hematology & Oncology · 2020 · 129 citations · Full text

Medicine, Oncology, Pharmacology +15

MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma

Chongsheng Qian, Ling-Jie Li, Haiwen Huang et al. · Cancer Cell International · 2020 · 65 citations · Full text

Medicine, Molecular Biology, Oncology +17

Expression and function of toll‐like receptors in multiple myeloma patients: toll‐like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor‐κB

Yang Xu, Yun Zhao, Haiwen Huang et al. · British Journal of Haematology · 2010 · 53 citations

Life Sciences, Immunology, Oncology +15

Chimeric antigen receptor T cells targeting FcRH5 provide robust tumour-specific responses in murine xenograft models of multiple myeloma

Dongpeng Jiang, Haiwen Huang, K J Tang et al. · Nature Communications · 2023 · 36 citations · Full text

Medicine, Immunology, Oncology +17